Veriphi Shareholder Update: 24 July 2017

ACH Hospital Pharmacy Trials.  Trials at Auckland City Hospital commenced on Saturday 22 July, on 5 oncology drugs. As a first step, we captured preliminary indicative data on each of the drugs, each in a single container, to see how well separated the drug signatures are. The initial data showed good separation between all drugs with less separation between two oncology drugs that are enantiomers (molecular mirror images of each other). The next step is to collect more data to determine how robust these differences are. In summary, a good start.

 Compliance Testing. Compliance testing also commenced last week with Kyle Pennington traveling to a testing laboratory, to conduct tests on the analyser, for commercial standards compliance. Our goal is to have local standards compliance by the end of September.